Products 2349386-89-4
CAS 2349386-89-4 appears in our catalog under these names: Molnupiravir, 100 mg, Molnupiravir, EIDD-2801/ 99.66% (existing batch purity), EIDD–2801, Molnupiravir - Bio-X â„¢. Offered by: Roth, Chemat Brand, TargetMol, GLPBio, Biosynth. Available pack sizes: 100mg, on request, 1g, 5mg, 10mg, 25mg, 50mg, 200mg.
Molnupiravir is a nucleoside analogue that is N4-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N4-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19. It has a role as an anticoronaviral agent, an antiviral drug and a prodrug. It is a ketoxime, an isopropyl ester and a nucleoside analogue. It is functionally related to a N(4)-hydroxycytidine.
Source: ChEBI
| Molecular formula | C13H19N3O7 |
|---|---|
| Molecular weight | 329.31 g/mol |
| IUPAC name | [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate |
| InChIKey | HTNPEHXGEKVIHG-QCNRFFRDSA-N |
| SMILES | CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O |
Computed by PubChem (NCBI)
Synonyms:
molnupiravir, Lagevrio, Uridine, 4-oxime, 5'-(2-methylpropanoate), Eidd 1931-isopropyl ester, beta-D-N4 Hydroxycytidine-5'-isopropyl ester, N4-Hydroxycytidine, 5'-isopropyl ester, Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-, SARS-CoV-2 antiviral agents: molnupiravir, Molnupiravir [INN], Molnupiravir [USAN]